Sirtuin 6 Inhibits Group 3 Innate Lymphoid Cell Function and Gut Immunity by Suppressing IL-22 Production

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Sep 10

PMID 39253083

Authors

Xiaohui Su

Linfeng Zhao

Huasheng Zhang

Dongdi Wang

Jiping Sun

Lei Shen

Affiliations

Soon will be listed here.

Abstract

Introduction: Group 3 innate lymphoid cells (ILC3s) are enriched in the intestinal mucosa and play important roles in host defense against infection and inflammatory diseases. Sirtuin 6 (SIRT6) is a nicotinamide adenine dinucleotide (NAD+)- dependent deacetylase and has been shown to control intestinal epithelial cell differentiation and survival. However, the role of SIRT6 in ILC3s remains unknown.

Methods: To investigate the role of SIRT6 in gut ILC3s, we generated SIRT6 conditional knockout mice by crossing Rorccre and Sirt6flox/flox mice. Cell number and cytokine production was examined using flow cytometry. Citrobacter rodentium infection and dextran sodium sulfate-induced colitis models were used to determine the role of SIRT6 in gut defense. RT-qPCR, flow cytometry and immunohistochemistry were used to assess the intestinal inflammatory responses.

Results: Here we show that SIRT6 inhibits IL-22 expression in intestinal ILC3s in a cell-intrinsic manner. Deletion of SIRT6 in ILC3s does not affect the cell numbers of total ILC3s and subsets, but results in increased IL-22 production. Furthermore, ablation of SIRT6 in ILC3s protects mice against Citrobacter rodentium infection and dextran sodium sulfate-induced colitis. Our results suggest that SIRT6 may play a role in ILC3 function by regulating gut immune responses against bacterial infection and inflammation.

Discussion: Our finding provided insight into the relation of epigenetic regulators with IL-22 production and supplied a new perspective for a potential strategy against inflammatory bowel disease.

References

Li J, Doty A, Tang Y, Berrie D, Iqbal A, Tan S . Enrichment of IL-17A IFN-γ and IL-22 IFN-γ T cell subsets is associated with reduction of NKp44 ILC3s in the terminal ileum of Crohn's disease patients. Clin Exp Immunol. 2017; 190(1):143-153. PMC: 5588779. DOI: 10.1111/cei.12996. View

Xiong X, Yang C, He W, Yu J, Xin Y, Zhang X . Sirtuin 6 maintains epithelial STAT6 activity to support intestinal tuft cell development and type 2 immunity. Nat Commun. 2022; 13(1):5192. PMC: 9440928. DOI: 10.1038/s41467-022-32846-4. View

Martinez-Lopez M, Iborra S, Conde-Garrosa R, Mastrangelo A, Danne C, Mann E . Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity. Immunity. 2019; 50(2):446-461.e9. PMC: 6382412. DOI: 10.1016/j.immuni.2018.12.020. View

Castleman M, Dillon S, Purba C, Cogswell A, Kibbie J, McCarter M . Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms. Front Immunol. 2019; 10:649. PMC: 6450192. DOI: 10.3389/fimmu.2019.00649. View

Michishita E, Park J, Burneskis J, Barrett J, Horikawa I . Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell. 2005; 16(10):4623-35. PMC: 1237069. DOI: 10.1091/mbc.e05-01-0033. View

Hernandez D, Juelke K, Muller N, Durek P, Ugursu B, Mashreghi M . An in vitro platform supports generation of human innate lymphoid cells from CD34 hematopoietic progenitors that recapitulate ex vivo identity. Immunity. 2021; 54(10):2417-2432.e5. DOI: 10.1016/j.immuni.2021.07.019. View

Choudhary C, Kumar C, Gnad F, Nielsen M, Rehman M, Walther T . Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009; 325(5942):834-40. DOI: 10.1126/science.1175371. View

Allan D, Kirkham C, Aguilar O, Qu L, Chen P, Fine J . An in vitro model of innate lymphoid cell function and differentiation. Mucosal Immunol. 2014; 8(2):340-51. DOI: 10.1038/mi.2014.71. View

Serafini N, Jarade A, Surace L, Goncalves P, Sismeiro O, Varet H . Trained ILC3 responses promote intestinal defense. Science. 2022; 375(6583):859-863. PMC: 10351749. DOI: 10.1126/science.aaz8777. View

10.

Ahn Y, Blazar B, Miller J, Verneris M . Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells. Blood. 2013; 121(12):2234-43. PMC: 3606063. DOI: 10.1182/blood-2012-07-440099. View

11.

Wang B, Lim J, Kajikawa T, Li X, Vallance B, Moutsopoulos N . Macrophage β2-Integrins Regulate IL-22 by ILC3s and Protect from Lethal Citrobacter rodentium-Induced Colitis. Cell Rep. 2019; 26(6):1614-1626.e5. PMC: 6404229. DOI: 10.1016/j.celrep.2019.01.054. View

12.

Li Y, Jin J, Wang Y . SIRT6 Widely Regulates Aging, Immunity, and Cancer. Front Oncol. 2022; 12:861334. PMC: 9019339. DOI: 10.3389/fonc.2022.861334. View

13.

Liu F, Bu H, Geng H, De Plaen I, Gao C, Wang P . Sirtuin-6 preserves R-spondin-1 expression and increases resistance of intestinal epithelium to injury in mice. Mol Med. 2018; 23:272-284. PMC: 5654826. DOI: 10.2119/molmed.2017.00085. View

14.

Artis D, Spits H . The biology of innate lymphoid cells. Nature. 2015; 517(7534):293-301. DOI: 10.1038/nature14189. View

15.

Bando J, Gilfillan S, Song C, McDonald K, Huang S, Newberry R . The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells. Immunity. 2018; 48(6):1208-1219.e4. PMC: 6086389. DOI: 10.1016/j.immuni.2018.04.012. View

16.

Gunasekera D, Ma J, Vacharathit V, Shah P, Ramakrishnan A, Uprety P . The development of colitis in Il10 mice is dependent on IL-22. Mucosal Immunol. 2020; 13(3):493-506. PMC: 7566780. DOI: 10.1038/s41385-019-0252-3. View

17.

Bauche D, Joyce-Shaikh B, Fong J, Villarino A, Ku K, Jain R . IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis. Sci Immunol. 2020; 5(46). DOI: 10.1126/sciimmunol.aav1080. View

18.

Gerriets V, Kishton R, Nichols A, Macintyre A, Inoue M, Ilkayeva O . Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest. 2014; 125(1):194-207. PMC: 4382238. DOI: 10.1172/JCI76012. View

19.

Zheng Y, Valdez P, Danilenko D, Hu Y, Sa S, Gong Q . Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008; 14(3):282-9. DOI: 10.1038/nm1720. View

20.

Gerner R, Klepsch V, Macheiner S, Arnhard K, Adolph T, Grander C . NAD metabolism fuels human and mouse intestinal inflammation. Gut. 2017; 67(10):1813-1823. PMC: 6145287. DOI: 10.1136/gutjnl-2017-314241. View